Analysis: ICICI Lombard General Insurance Company Limited

NSE:ICICIGI Finance - Non Life Insurance Market cap: ₹75.5K cr

Growth thesis

ICICI Lombard is a multi-line general insurance company operating across motor, health, and commercial insurance segments, generating revenue through gross written premium and investment income. The business sits as a direct underwriter in the financial value chain, competing against over 30 industry players, yet holding a dominant 10.5% motor market share and leadership in marine cargo and liability lines as of Q1 FY2027. Business quality is exceptional, evidenced by a 10-year average combined ratio of 102.9% through FY2025 against an industry average of 115.3%. This underwriting profitability translates to high returns on equity, with the company delivering a 19.1% ROE in FY2025 and an 18.1% ROE in FY2026, excluding a one-time wage code impact, placing it firmly in the compounder category.

The economics of this business persist through a combination of scale-driven expense management and structural underwriting discipline. The data shows a 14 percentage point combined ratio gap versus the industry in FY2026, driven by a motor combined ratio differential that widened to 21.4% from 18.4% in FY2025. This advantage is underpinned by a cashless garage network of 15,000 partners and digital claims processing where 96.8% of motor own damage claims were paid within 30 days for 9M FY2026. Furthermore, 21 out of 34 industry players exceed the 30% expense of management regulatory threshold, while ICICI Lombard operates strictly within limits, demonstrating a cost advantage that restricts competitors from sustaining underwriting losses. Industry solvency dropped to 1.56x by March 2026, further limiting irrational pricing competition.

The 18 to 24 month inflection hinges on retail health market share conversion and the eventual transition to Ind AS accounting. Retail health market share expanded from 3.3% in FY2025 to 4.5% in Q1 FY2027, driven by 69.5% growth in that quarter and a GST exemption tailwind. By FY2027, the long-term book contribution in retail health new business reached 53.4%, up from 31.8% a year prior, locking in future premium visibility. The Ind AS transition is expected to reduce the combined ratio by 300 to 450 basis points in the year of adoption, though management is seeking first-year forbearance. By FY2027, the business is targeted to sustain an 18 to 20% ROE while maintaining top-line growth 100 to 200 basis points ahead of the industry.

Management has consistently delivered on its stated targets across the last four quarters. They promised 100 to 200 basis points of out-performance against industry growth, which materialized as FY2026 gross direct premium income growing 11% versus 6.2% for the industry, and Q1 FY2027 motor growth of 14% against an industry showing higher single-digit growth. Guidance for an 18 to 20% ROE was met in FY2025 with 19.1% and narrowly missed in FY2026 at 18.1% due to a 0.55 billion wage code impact. Capital allocation remains conservative with a solvency ratio of 2.71x as of June 2026 against a 1.50x regulatory minimum, zero reliance on external dilution, and a fixed dividend policy targeting roughly 25% of profit after tax, evidenced by a 13.50 per share dividend for FY2026.

Earnings visibility is anchored by a 65 to 67% targeted motor loss ratio and a 65 to 70% retail health loss ratio, supported by 584.21 billion in investment assets generating a 7.58% yield as of FY2026. For this trajectory to hold, commercial lines must recover from a 13.8% de-growth in Q1 FY2027 caused by extreme pricing aggression, and the industry must absorb the recent Supreme Court judgement on motor third-party claims without permanent margin destruction. The single most important watchpoint is the 1.65 billion provision taken in Q1 FY2027 for this judgement, which is expected to increase the industry motor third-party loss ratio by 12 to 15%. If regulatory premium rate revisions do not materialize to offset this structural shift, the motor underwriting margin could face sustained compression.

Why is ICICI Lombard General Insurance Company Limited stock rising?

  • Ind AS transition expected to reduce combined ratio by 300-450 bps in year of adoption; company will submit Ind AS results to regulator while seeking forbearance for statutory reporting
  • Public Insurance Registry (PIR) expected to become key pillar of Digital Public Infrastructure, supporting industry growth, efficiency, and transparency
  • IL OneForce enterprise productivity platform on track to become single operating platform for all 15,000+ employees
  • IL TakeCare app to be continuously enhanced as one-stop solution for insurance and wellness; focus on improving digital DIY service experience
  • One IL One Call Centre initiative driving transition to digital-first DIY servicing; target to increase digital engagement share from current levels

Research report

companyname: ICICI Lombard General Insurance Company Limited ticker: ICICIGI sector: General Insurance / Non-Life Insurance ICICI Lombard is one of India's largest private general insurers, formed in 2001 as a joint venture between ICICI Bank and Fairfax Financial Holdings. The company completed 25 years of operations in FY2026, having served over 500 million customers since inception and processed over 60 million claims. It underwrites non-life insurance across Motor, Health, Crop and Weather,...

Read the full report →

Catalysts

capex, margin expansion, regulatory approval, market share gain

Growth guidance

Growth: 100-200 bps above industry; ROE: 18-20% range for FY27

Guidance maintained

Management consistency

consistent

RS rating: 9 Stage: Stage 4

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for ICICI Lombard General Insurance Company Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.